advertisement
2.1 Conjunctiva (26)
Showing records 1 to 25
Display all abstracts in classification 2.1 Conjunctiva
Search within classification 2.1 Conjunctiva69833 Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital Glaucoma
Li X
Journal of Glaucoma 2016; 25: e855-e860
70581 Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent
Mlčáková E
Česka a Slovenska Oftalmologie 2016; 72: 120-127
69977 The Association of Chronic Topical Prostaglandin Analog Use With Meibomian Gland Dysfunction
Mocan MC
Journal of Glaucoma 2016; 25: 770-774
70663 Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4
Terao E
Current Eye Research 2016; 0: 1-5
70273 Tear Lipid Layer Thickness Change and Topical Anti-Glaucoma Medication Use
Lee SY
Optometry and Vision Science 2016; 93: 1210-1217
69833 Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital Glaucoma
Mukkamala L
Journal of Glaucoma 2016; 25: e855-e860
70663 Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4
Nakakura S
Current Eye Research 2016; 0: 1-5
69977 The Association of Chronic Topical Prostaglandin Analog Use With Meibomian Gland Dysfunction
Uzunosmanoglu E
Journal of Glaucoma 2016; 25: 770-774
70273 Tear Lipid Layer Thickness Change and Topical Anti-Glaucoma Medication Use
Lee H
Optometry and Vision Science 2016; 93: 1210-1217
70581 Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent
Mlčák P; Karhanová M
Česka a Slovenska Oftalmologie 2016; 72: 120-127
69977 The Association of Chronic Topical Prostaglandin Analog Use With Meibomian Gland Dysfunction
Kocabeyoglu S
Journal of Glaucoma 2016; 25: 770-774
70663 Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4
Fujisawa Y
Current Eye Research 2016; 0: 1-5
70273 Tear Lipid Layer Thickness Change and Topical Anti-Glaucoma Medication Use
Bae HW
Optometry and Vision Science 2016; 93: 1210-1217
69833 Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital Glaucoma
Origlieri CA
Journal of Glaucoma 2016; 25: e855-e860
70273 Tear Lipid Layer Thickness Change and Topical Anti-Glaucoma Medication Use
Kim TI
Optometry and Vision Science 2016; 93: 1210-1217
69833 Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital Glaucoma
Holland BK
Journal of Glaucoma 2016; 25: e855-e860
70581 Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent
Langová K
Česka a Slovenska Oftalmologie 2016; 72: 120-127
69977 The Association of Chronic Topical Prostaglandin Analog Use With Meibomian Gland Dysfunction
Karakaya J
Journal of Glaucoma 2016; 25: 770-774
70663 Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4
Fujio Y; Matsuya K
Current Eye Research 2016; 0: 1-5
70581 Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent
Marešová K
Česka a Slovenska Oftalmologie 2016; 72: 120-127
69833 Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital Glaucoma
Fechtner RD
Journal of Glaucoma 2016; 25: e855-e860
69977 The Association of Chronic Topical Prostaglandin Analog Use With Meibomian Gland Dysfunction
Irkec M
Journal of Glaucoma 2016; 25: 770-774
70273 Tear Lipid Layer Thickness Change and Topical Anti-Glaucoma Medication Use
Kim CY
Optometry and Vision Science 2016; 93: 1210-1217
70663 Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4
Kobayashi Y
Current Eye Research 2016; 0: 1-5
69833 Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital Glaucoma
Khouri AS
Journal of Glaucoma 2016; 25: e855-e860